United Therapeutics | UTHR - 销售收入



金融业
股票价格
USD 541.51
资产
USD 7.22B
现金及等价物
USD 1.8B
销售成本
USD 99.5M
流动资产
USD 3.48B
流动负债
USD 607.8M
债务
USD 200M
EBIT
USD 375.6M
EBITDA
USD 355M
员工
1.31K
EPS每股收益
USD 7.27
股本和储备
USD 6.4B
销售毛利
USD 683.8M
债务利息支出
USD 2.9M
利息收入
USD 31.5M
贷款资金
USD 100M
市值
USD 25.79B
净收入
USD 333M
营业费用
USD 6.4B
营业利润
USD 330.8M
普通股股本
USD 42.68M
PE价格收益
19.15
税前利润
USD 372.7M
销售收入
USD 783.3M
销售和管理费用
USD 206.7M
股票
USD 193.8M
贸易债权人
USD 497.8M
应收帐款人
USD 310.3M


销售 更改 日
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 94.47M 30.74M 2026-03
Baxter International USD 2.96B 260M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.74B 490M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Halozyme Therapeutics USD 481M 104M 2026-06
Insmed USD 425.49M 119.53M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
J&J USD 25.4B 89M 2026-09
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Moderna USD 100M 289M 2026-06
Pfizer USD 15.03B 530M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06